busulfan has been researched along with Genetic Predisposition in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jurkovic Mlakar, S | 2 |
| Uppugunduri, SCR | 1 |
| Nava, T | 2 |
| Mlakar, V | 1 |
| Golay, H | 1 |
| Robin, S | 1 |
| Waespe, N | 1 |
| Rezgui, MA | 2 |
| Chalandon, Y | 2 |
| Boelens, JJ | 2 |
| Bredius, RGM | 2 |
| Dalle, JH | 2 |
| Peters, C | 2 |
| Corbacioglu, S | 1 |
| Bittencourt, H | 2 |
| Krajinovic, M | 2 |
| Ansari, M | 2 |
| Petrykey, K | 1 |
| Del Vecchio, V | 1 |
| Cortyl, J | 1 |
| Ralph, RO | 1 |
| Beaulieu, P | 1 |
| St-Onge, P | 1 |
| Huezo-Diaz Curtis, P | 1 |
| Uppugunduri, CRS | 1 |
| Lesne, L | 1 |
| Théoret, Y | 1 |
| Bartelink, IH | 1 |
| Lewis, V | 1 |
| Kangarloo, BS | 1 |
| Sinnett, D | 1 |
| Efrati, E | 1 |
| Zuckerman, T | 1 |
| Ben-Ami, E | 1 |
| Krivoy, N | 1 |
| Srivastava, A | 1 |
| Poonkuzhali, B | 1 |
| Shaji, RV | 1 |
| George, B | 1 |
| Mathews, V | 1 |
| Chandy, M | 1 |
| Krishnamoorthy, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Polymorphisms and Busulfan Pharmacokinetic Study in Pediatric Transplnatation[NCT01257854] | 200 participants (Anticipated) | Observational | 2008-02-29 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for busulfan and Genetic Predisposition
| Article | Year |
|---|---|
Glutathione S-transferase M1 polymorphism: a risk factor for hepatic venoocclusive disease in bone marrow transplantation.
Topics: Adolescent; beta-Thalassemia; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Cyclop | 2004 |
3 other studies available for busulfan and Genetic Predisposition
| Article | Year |
|---|---|
GSTM1 and GSTT1 double null genotypes determining cell fate and proliferation as potential risk factors of relapse in children with hematological malignancies after hematopoietic stem cell transplantation.
Topics: Adolescent; Biomarkers, Tumor; Busulfan; Cell Line, Tumor; Cell Proliferation; Child; Child, Prescho | 2022 |
Genetic Susceptibility to Hepatic Sinusoidal Obstruction Syndrome in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation.
Topics: Busulfan; Child; Genetic Predisposition to Disease; Glucuronosyltransferase; Hematopoietic Stem Cell | 2020 |
MTHFR C677T/A1298C genotype: a possible risk factor for liver sinusoidal obstruction syndrome.
Topics: Busulfan; Genetic Predisposition to Disease; Genotype; Hepatic Veno-Occlusive Disease; Humans; Methy | 2014 |